您的位置: 首页 > 农业专利 > 详情页

Methods of use for IL-22 in the treatment of gastrointestinal graft vs. host disease
专利权人:
Memorial Sloan-Kettering Cancer Center; Ltd.;Generon (Shanghai) Corporation, Ltd.;Generon (Shanghai) Corporation
发明人:
Van Den Brink, Marcel,Hanash, Alan,Lindemans, Caroline,Tang, Tom
申请号:
AU2014346554
公开号:
AU2014346554A1
申请日:
2014.11.07
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The disclosure provides methods and compositions for the use of IL-22 for treating conditions of intestinal injury and inflammatory conditions such as graft vs. host disease. Specifically, IL-22 can be used to increase Intestinal Stern Cell (ISC) recovery and for enhancing immune reconstitution following allogeneic hematopoietic transplantation. More specifically, the disclosure provides methods of using therapeutic IL-22, including a dimeric form of IL-22, in therapeutic compositions for treating graft vs. host disease, including hepatic, thymic, gastrointestinal, or other graft vs. host disease in hematopoietic stem cell transplant patients and in patients with inflammatory intestinal conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充